Patients with intermediate risk chest pain may be safely assessed within 12 hours of presenting to ER with stress cardiac MR imaging.
Performing adenosine stress cardiac MR imaging within 12 hours of patients presenting to the emergency room with complaints of intermediate-risk chest pain is safe when compared with stress echocardiography, according to a study published in the journal Radiology.
Researchers from Duke University sought to compare the utility and efficacy of stress cardiac MR imaging and stress echocardiography in patients who presented to the emergency room with acute chest pain and intermediate risk of coronary artery disease (CAD).
Sixty patients with chest pain and no previous history of CAD participated in the study. Follow-up was 14 months, ±5 months. All patients underwent both stress cardiac MR imaging and stress echocardiography in random order within 12 hours of presentation to the emergency room. Coronary angiogram was performed if either test result was abnormal.
In evaluating the results, CAD was considered significant if identified during angiography (narrowing of more than 50 percent) or if a myocardial infarction or death occurred during follow-up. The results showed that both stress cardiac MR imaging and stress echocardiography were similar in specificity, accuracy and predictive values:
Specificity
Accuracy
Predictive values
Pos/neg
Stress cardiac MR imaging
92 percent
93 percent
67 percent/
60 percent
Stress echocardiography
96 percent
88 percent
100 percent/
91 percent
The researchers concluded that for patients who presented to the emergency room with intermediate risk chest pain, “adenosine cardiac MR imaging performed within 12 hours of presentation is safe and potentially has improved performance characteristics compared with stress echocardiography.”
Enhancing Lesions on Breast MRI: Can an Updated Kaiser Scoring Model Improve Detection?
September 26th 2024The addition of parameters such as patient age, MIP sign and associated imaging features to the Kaiser score demonstrated a 95.6 percent AUC for breast cancer detection of enhancing lesions on breast MRI in recently published research.
MRI or Ultrasound for Evaluating Pelvic Endometriosis?: Seven Takeaways from a New Literature Review
September 13th 2024While noting the strength of MRI for complete staging of disease and ultrasound’s ability to provide local disease characterization, the authors of a new literature review suggest the two modalities offer comparable results for diagnosing pelvic endometriosis.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.